Cargando…
Definition of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients
Glioblastoma (GB) is an aggressive type of tumour for which therapeutic options and biomarkers are limited. GB diagnosis mostly relies on symptomatic presentation of the tumour and, in turn, brain imaging and invasive biopsy that can delay its diagnosis. Description of easily accessible and effectiv...
Autores principales: | Cilibrasi, Chiara, Simon, Thomas, Vintu, Marian, Tolias, Christos, Samuels, Mark, Mazarakis, Nektarios K., Eravci, Murat, Stewart, Nicolas, Critchley, Giles, Giamas, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773644/ https://www.ncbi.nlm.nih.gov/pubmed/35052804 http://dx.doi.org/10.3390/biomedicines10010125 |
Ejemplares similares
-
Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping
por: Lane, Rosemary, et al.
Publicado: (2019) -
Shooting the messenger: a systematic review investigating extracellular vesicle isolation and characterisation methods and their influence on understanding extracellular vesicles-radiotherapy interactions in glioblastoma
por: Robinson, Stephen David, et al.
Publicado: (2023) -
Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment
por: Samuels, Mark, et al.
Publicado: (2022) -
PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38(MAPK) signalling
por: Lane, Rosemary, et al.
Publicado: (2022) -
Breaking through the glioblastoma micro-environment via extracellular vesicles
por: Simon, Thomas, et al.
Publicado: (2020)